COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00875979
Brief Title: A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab

First Submitted : April 2, 2009
First Submitted that Met QC Criteria : April 2, 2009
First Posted : April 6, 2009 (Estimate)

Results First Submitted : February 22, 2013
Results First Submitted that Met QC Criteria : June 13, 2013
Results First Posted : July 18, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : December 20, 2013
Last Update Posted : December 24, 2013 (Estimate)